3 Questions: Ram Sasisekharan on hastening vaccines and treatments
Biological engineer discusses condensing the time taken to develop therapeutics down from many years to a matter of months.
Biological engineer discusses condensing the time taken to develop therapeutics down from many years to a matter of months.
Awards to be used for ongoing work with older adults.
Far from MIT, nuclear science and engineering students take ownership of projects and explore new terrain.
New technique provides a means of interconnection between processors, opening the way to a complete quantum computing platform.
Large datasets are difficult to depict as scatterplots — but that may change with a new CSAIL project for creating interactive visualizations.
With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.
Michael Birnbaum, Anders Hansen, and Tami Lieberman receive NIH Director’s New Innovator Awards from the NIH Common Fund’s High-Risk, High-Reward Research program.
Researchers urge a holistic approach to forecasting the virus’ impact on public health and the economy.
Remarkably large cohort of graduating seniors honored for excellence in the liberal arts.
Normally an insulator, diamond becomes a metallic conductor when subjected to large strain in a new theoretical model.
Using these new particles, researchers could develop treatments for heart disease and other conditions.
In some situations, asking “what if everyone did that?” is a common strategy for judging whether an action is right or wrong.
MIT senior Darya Guettler advocates for climate action and broader deployment of zero-carbon energy sources.
Professor Yossi Sheffi's latest book, “The New (Ab)Normal,” offers a key supply chain perspective on the pandemic.
MIT researchers find blocking the expression of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.